These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14759396)

  • 21. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.
    Duray GZ; Israel CW; Pajitnev D; Hohnloser SH
    Europace; 2008 Jan; 10(1):48-52. PubMed ID: 18077483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different criteria of cardiac resynchronization therapy and their prognostic value for worsening heart failure or major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Fauchier L; Poret P; Robin I; de Labriolle A; Giraudeau C; Cosnay P; Babuty D
    Am J Cardiol; 2006 Feb; 97(3):393-9. PubMed ID: 16442403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of heart rate during exercise for response to cardiac resynchronization therapy.
    Maass AH; Buck S; Nieuwland W; Brügemann J; van Veldhuisen DJ; Van Gelder IC
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):773-80. PubMed ID: 19207785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach.
    Gasparini M; Galimberti P; Regoli F; Ceriotti C; Bonadies M
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1279-83. PubMed ID: 16403056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
    Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
    J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontiers in congestive heart failure: initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
    Tepper D
    Congest Heart Fail; 2002; 8(2):91. PubMed ID: 11927784
    [No Abstract]   [Full Text] [Related]  

  • 31. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
    Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
    Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early warning system for pulmonary fluid status monitoring in terminal heart failure].
    Wedekind H; Möller K
    Dtsch Med Wochenschr; 2007 Mar; 132(11):555-9. PubMed ID: 17342631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
    Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study].
    García-Pinilla JM; Jiménez-Navarro MF; Anguita-Sánchez M; Martínez-Martínez A; Torres-Calvo F;
    Rev Esp Cardiol; 2007 Jan; 60(1):38-44. PubMed ID: 17288954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial.
    Kutalek SP; Sharma AD; McWilliams MJ; Wilkoff BL; Leonen A; Hallstrom AP; Kudenchuk PJ;
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):828-37. PubMed ID: 18684279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac-resynchronization therapy.
    Owen A
    N Engl J Med; 2010 Jan; 362(2):178-9; author reply 179. PubMed ID: 20077592
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry.
    Gilliam FR; Kaplan AJ; Black J; Chase KJ; Mullin CM
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):56-64. PubMed ID: 17241316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
    Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
    Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.